PR NEWSWIRE

Previous Stories

Coway Announces Their First Amazon Australia Prime Day Sale

Jul 11 2022 - PR NewsWire

SYDNEY, July 11, 2022 /PRNewswire/ – Today, South Korea’s home health company and world-leading air purifier brand Coway announces their first…


ZIRCON Phase III Kidney Cancer Imaging Study Completes Enrolment

Jul 11 2022 - PR NewsWire

MELBOURNE, Australia, July 11, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has dosed…


Kevin Richardson appointed as CEO, Telix Americas

Jul 11 2022 - PR NewsWire

MELBOURNE and INDIANAPOLIS, July 11, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is pleased to announce that Kevin…


40 Best Wines in the World as judged at the International Wine Challenge 2022

Jul 08 2022 - PR NewsWire

LONDON, July 8, 2022 /PRNewswire/ — The International Wine Challenge, the world’s most influential, impartial and rigorously judged wine competition,…


HIF Global begins approval process for its first carbon neutral eFuels manufacturing facility in Australia

Jul 08 2022 - PR NewsWire

Located in Tasmania, the facility plans to produce up to 100 million litres per year of carbon neutral eFuels SYDNEY,…


HaemaLogiX strengthens Board with appointment of Dr. Geoff Nichol

Jul 08 2022 - PR NewsWire

Dr. Geoff Nichol, M.B., Ch.B., M.B.A., joins HaemaLogiX’s Board of Directors as Non-Executive Director, bringing nearly 30 years of global…


Coway’s Award-Winning Airmega Air Purifiers Finally Come to Australia

Jul 07 2022 - PR NewsWire

Coway launches their award-winning "Coway Airmega" lineup exclusively on Amazon Australia The ‘Coway Airmega Mighty,’ a favourite with New York…


Alterity Therapeutics Doses First Patient in ATH434 Phase 2 Clinical Trial in Multiple System Atrophy

Jul 07 2022 - PR NewsWire

MELBOURNE, Australia and SAN FRANCISCO, July 6, 2022 /PRNewswire/ — Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"),…


US FDA AWARDS RARE PEDIATRIC DISEASE DESIGNATION (RPDD) TO PAXALISIB FOR AT/RT, A RARE FORM OF CHILDHOOD BRAIN CANCER

Jul 06 2022 - PR NewsWire

SYDNEY, July 6, 2022 /PRNewswire/ — Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased…


Digital Nomads Hq Has Hit an All-time High in Growth and Acquisition of New Business Partnerships

Jul 05 2022 - PR NewsWire

Digital Agency Booming Through the Current Australian Financial Crisis The current economic climate in Australia is driving businesses to look…


Analyse The Market From A Different Angle